06 Aug 2002
The world's biggest medical laser company sees growth in the aesthetic and ophthalmic sectors.
Israel-based Lumenis, the world's biggest medical laser system manufacturer, has reported rising revenues in its second-quarter results.
Total income for the quarter was USD 92.2 million, up from USD 80.4 million in the same quarter last year.
The increase in revenues did not translate into a net profit, however, which was wiped out thanks to a USD 5.2 million charge from a resolved lawsuit.
Overall, Lumenis saw steady sales growth in the US and Asian markets. These outweighed continued weak sales in Europe, which the company put down to ongoing changes in management structures.
"We continue to experience weak results in Europe, but with our new management team in place, we expect improvements by the end of the year," said Lumenis chief executive Yacha Sutton.
Sales in the aesthetic market rose by around 8% on the previous year, with photorejuvenation products doing well in the US and Asia.
Ophthalmology revenues saw a 25% increase on the previous year, boosted by a new product for treating glaucoma increasing demand for refractive equipment for laser eye surgery.
The surgical sector saw a drop of around 10%, which Lumenis blamed on a drop-of in demand for veterinary products.
Michael Hatcher is technology editor of Opto and Laser Europe magazine.